Improving the Odds of a Successful Contract Research Project – Results from a Sponsor-Vendor Collaboration

Author(s)

Moderator: Bill Marder, PhD, IBM Watson Health, Winchester, MA, USA
Panelists: Ami Buikema, MPH, HEOR, Optum, Eden Prairie, MN, USA; David L. Van Brunt, PhD, MS, BA, Evidence and Analytics, Health Economics and Outcomes Research, AbbVie, Chicago, IL, USA; Khalid Kamal Kamal, MPharm, PhD, West Virginia University, Morgantown, WV, USA

ISSUE

: The pharmaceutical industry funds thousands of research projects each year. Most projects run smoothly but problems do arise. This panel will identify a set of common issues and recommend some best practices for successful engagements.

OVERVIEW

: In 2020, the ISPOR Institutional Council (IC) undertook a study to better understand sponsor-vendor interactions. A qualitative survey of IC members was conducted, results of which were utilized to develop a quantitative survey questionnaire. The questionnaire was completed by 158 ISPOR members who were either sponsors or vendors and involved in contract research. Four major issues were identified: 1) managing changes to scope and time, 2) achieving the quality expected for the project, 3) prompt/ timely reply as issues arise, and 4) stability of staffing/leadership (and managing turnover).OVERVIEW

A working group and then the full IC identified project management strategies that could minimize the potential impact of each of these issues.

This issue panel will present the result of this project and solicit comments and suggestions to further enhance the probability of successful sponsored HEOR projects.

Conference/Value in Health Info

2021-05, ISPOR 2021, Montreal, Canada

Topic

Organizational Practices

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×